Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Guardant Health stock surges on colon cancer blood test news

Дата публикации: 05-07-2026 15:33:00

Guardant Health (GH) investors have a new number to think about this week.  Bernstein SocGen Group raised its price target on the cancer-screening company's stock to $200 a share, up from $175. Bernstein also kept its Outperform rating intact. The new price target came less than a day after a ...

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Morgan Stanley unveils key Monster stock price prediction6704-07-2026
2Goldman Sachs doubles down on Robinhood stock after record trading surge7805-07-2026
3Top Analyst strongly resets AMD stock price target5705-07-2026
4Top analyst has bold Costco stock outlook for 20260505-07-2026
5Warren Buffett unveils 11-word stock market warning0505-07-2026
6 Why Palantir’s success will outlast AI exuberance -2305-11-2025
7Jim Cramer makes bold buy call on one booming energy stock7604-07-2026
8Акции "Сегежа груп" на Мосбирже растут более чем на 5% на публикации отчетности0002-11-2021
9Pandemic darlings Moderna, BioNTech are now on two different paths0731-07-2025
10SpaceX scores big as stock soars and people are starting to bet on it8713-06-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 6. Информативность: 7. Источник: www.thestreet.com.